Changing the landscape of pediatric cancer
The Mikaela Naylon Give Kids a Chance Act is Passed into Law! · 2.3.2026
PRV is reauthorized!
Drug companies will study combinations of cancer drugs for kids! Because new cures need new combinations of drugs.
Companies that fail to complete their pediatric studies will be now penalized, just as they have been when they fail to complete their adult studies.
The Lede with Jake Tapper
What kids have to say about pediatric cancer
Mikaela Naylon,16, MIB Agent at the FDA OSI Workshop, October 2025
Camille Brady, 23, MIB Agents Junior Advisory Board Member